Teva Pharmaceutical (TEVA) Reports In-Line Q2 EPS of $1.28
Tweet Send to a Friend
Teva Pharmaceutical (NASDAQ: TEVA) reported Q2 EPS of $1.28 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
